Clinical Trial Update: A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating RPh201 for efficacy and safety in mild to moderate Alzheimer's dementia with or without cerebrovascular disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cerebrovascular Disease
• Dementia Due to Alzheimer

Drugs mentioned

• RPh201

Snippet

Sponsor: Regenera Pharma Ltd | Conditions: Mild to Moderate Dementia Due to Alzheimer's Disease, With or Without Coexisting Cerebrovascular Disease | Phase 2 | Status: COMPLETED